Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin plus exenatide for weight loss in obese non-diabetic subjects
2014-003432-39Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Sep 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Dapagliflozin + exenatide with Placebo (2 arms). Started Sep 2014; status: completed.
02
Drugs
dapagliflozinexenatide
03
Conditions
obesity
Beyond the preview
Go deeper on 2014-003432-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003432-39.